对抗怪物的盾牌：血液透析患者中的丙型肝炎
A shield against a monster: Hepatitis C in hemodialysis patients.
作者信息
Alavian Seyed-Moayed
出版信息
World J Gastroenterol. 2009 Feb 14;15(6):641-6. doi: 10.3748/wjg.15.641.
Abstract
Hepatitis C virus (HCV) infection is highly prevalent among patients on hemodialysis (HD). The prevalence of HCV infection in HD patients varies markedly from country to country. Some factors are especially related to these high prevalence rates, such as blood transfusions and length of dialysis time. Nosocomial routes of transmission including the use of contaminated equipment and patient-to-patient exposure is considered more important. Several prophylactic measures have been suggested to avoid infection by HCV in the HD environment.
摘要
丙型肝炎病毒（HCV）感染在血液透析（HD）患者中极为普遍。HD患者中HCV感染的患病率在不同国家之间差异显著。一些因素与这些高患病率尤其相关，例如输血和透析时间长短。包括使用受污染设备以及患者之间的接触在内的医院内传播途径被认为更为重要。已经提出了几种预防措施以避免在HD环境中感染HCV。
相似文献
1
A shield against a monster: Hepatitis C in hemodialysis patients.
World J Gastroenterol. 2009 Feb 14;15(6):641-6. doi: 10.3748/wjg.15.641.
2
Impact of dedicated space, dialysis equipment, and nursing staff on the transmission of hepatitis C virus in a hemodialysis unit of the middle east.
Am J Infect Control. 2003 Feb;31(1):26-33. doi: 10.1067/mic.2003.55.
3
Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients.
Am J Kidney Dis. 2010 Aug;56(2):371-8. doi: 10.1053/j.ajkd.2010.01.025. Epub 2010 Jun 8.
4
Hepatitis C virus infection during haemodialysis in India.
J Assoc Physicians India. 1999 Dec;47(12):1139-43.
5
Hepatitis C in hemodialysis: epidemiology and prevention of hepatitis C virus transmission.
Contrib Nephrol. 2012;176:35-41. doi: 10.1159/000333761. Epub 2012 Jan 30.
6
[Prevalence of hepatitis C virus infection among chronic hemodialysis patients].
Hokkaido Igaku Zasshi. 1994 Sep;69(5):1178-88.
7
Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus.
Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):302-6. doi: 10.1016/s1499-3872(12)60164-7.
8
Trends in hepatitis C infection among hemodialysis patients in Senegal: results of a decade of prevention.
Saudi J Kidney Dis Transpl. 2014 Nov;25(6):1341-5. doi: 10.4103/1319-2442.144319.
9
Impact of dialysis room and reuse strategies on the incidence of hepatitis C virus infection in haemodialysis units.
Nephrol Dial Transplant. 1996 Oct;11(10):2017-22. doi: 10.1093/oxfordjournals.ndt.a027090.
10
Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors.
BMC Infect Dis. 2012 Oct 20;12:265. doi: 10.1186/1471-2334-12-265.
引用本文的文献
1
The prevalence of hepatitis C virus in hemodialysis patients in Pakistan: A systematic review and meta-analysis.
PLoS One. 2020 May 14;15(5):e0232931. doi: 10.1371/journal.pone.0232931. eCollection 2020.
2
Prevalence of hepatitis C infection in Iranian hemodialysis patients: An updated systematic review and meta-analysis.
J Res Med Sci. 2017 Nov 28;22:123. doi: 10.4103/jrms.JRMS_223_17. eCollection 2017.
3
Prevalence of hepatitis C virus infection among hemodialysis patients in the Middle-East: A systematic review and meta-analysis.
World J Gastroenterol. 2017 Jan 7;23(1):151-166. doi: 10.3748/wjg.v23.i1.151.
4
Epidemiology of hepatitis C in Croatia in the European context.
World J Gastroenterol. 2015 Aug 28;21(32):9476-93. doi: 10.3748/wjg.v21.i32.9476.
5
Management of hepatitis C virus infection in hemodialysis patients.
World J Hepatol. 2014 Jun 27;6(6):419-25. doi: 10.4254/wjh.v6.i6.419.
6
An unbelievable fact on "dialysis centers without hepatitis C infection".
Nephrourol Mon. 2014 Mar 1;6(2):e17998. doi: 10.5812/numonthly.17998. eCollection 2014 Mar.
7
Diagnostic Performance of an Immunoassay for Simultaneous Detection of Hcv Core Antigen and Antibodies among Haemodialysis Patients.
Braz J Microbiol. 2011 Jan;42(1):303-9. doi: 10.1590/S1517-83822011000100039.
8
Rising burden of Hepatitis C Virus in hemodialysis patients.
Virol J. 2011;8:438. doi: 10.1186/1743-422X-8-438. Epub 2011 Sep 13.
9
Management of the kidney transplant patient with chronic hepatitis C infection.
Int J Nephrol. 2011;2011:245823. doi: 10.4061/2011/245823. Epub 2011 Apr 26.
10
Renal dysfunction in chronic liver disease.
Crit Care. 2010;14(2):214. doi: 10.1186/cc8855. Epub 2010 Mar 9.
本文引用的文献
1
Dialysis in Iran.
Iran J Kidney Dis. 2008 Jan;2(1):11-5.
2
Prevalence of hepatitis C antibodies among hemodialysis patients in the Western province of saudi arabia.
Saudi J Kidney Dis Transpl. 1995 April-June;6(2):136-9.
3
The prevalence of hepatitis C virus antibodies among hemodialysis patients in jeddah area, saudi arabia.
Saudi J Kidney Dis Transpl. 1995 April-June;6(2):128-31.
4
Hepatitis C in hemodialysis patients: current global magnitude, natural history, diagnostic difficulties, and preventive measures.
Am J Nephrol. 2008;28(4):628-40. doi: 10.1159/000117573. Epub 2008 Feb 19.
5
[Hepatitis C serum prevalence in hemodialyzed patients].
Rev Soc Bras Med Trop. 2007 May-Jun;40(3):290-4. doi: 10.1590/s0037-86822007000300008.
6
Hepatitis C virus and death risk in hemodialysis patients.
J Am Soc Nephrol. 2007 May;18(5):1584-93. doi: 10.1681/ASN.2006070736. Epub 2007 Apr 11.
7
Infection by the hepatitis C virus in chronic renal failure patients undergoing hemodialysis in Mato Grosso state, central Brazil: a cohort study.
BMC Public Health. 2007 Mar 12;7:32. doi: 10.1186/1471-2458-7-32.
8
The impact of polymerase chain reaction assays for the detection of hepatitis C virus infection in a hemodialysis unit.
Saudi J Kidney Dis Transpl. 2007 Mar;18(1):107-13.
9
Hepatitis C virus infection in hemodialysis patients in Sudan: two centers' report.
Saudi J Kidney Dis Transpl. 2007 Mar;18(1):101-6.
10
Hepatitis C infection in risk groups.
Bosn J Basic Med Sci. 2006 Nov;6(4):13-7. doi: 10.17305/bjbms.2006.3111.
Zotero 插件